Antibody-mediated osseous regeneration: The early events in the healing response

Tissue Engineering - Part A

Volumn 19, Issue 9-10, 2013, Pages 1165-1174

  Freire, Marcelo O ^a   Kim, Hak Kyun ^b   Kook, Joong Ki ^c   Nguyen, Anthony ^a   Zadeh, Homayoun H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Chungnam National University   (South Korea)

^c Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BONE; CELL ENGINEERING; COMPUTERIZED TOMOGRAPHY; DEFECTS; ENZYME ACTIVITY; GENE EXPRESSION; MONOCLONAL ANTIBODIES; PROTEINS; RAT CONTROL; REPAIR; TISSUE;

BONE MORPHOGENETIC PROTEINS; DYSTROPHIC CALCIFICATION; EXTRACELLULAR ENVIRONMENTS; GENE EXPRESSION LEVELS; HISTOLOGICAL ANALYSIS; MICROCOMPUTED TOMOGRAPHY; MONOCLONAL ANTIBODIES (MAB); MORPHOGENETIC PROTEINS;

SCAFFOLDS (BIOLOGY);

RATTUS;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MONOCLONAL ANTIBODY; OSTEOGENIC PROTEIN 1;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CONFOCAL MICROSCOPY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE REGENERATION; FEMALE; HUMANS; MICROSCOPY, CONFOCAL; OSTEOGENESIS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84875599393     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0282     Document Type: Article

References (24)

1. Warren, S.M., Fong, K.D., Chen, C.M., Loboa, E.G., Cowan, C.M., Lorenz, H.P., et al. Tools and techniques for craniofacial tissue engineering. Tissue Eng 9, 187, 2003.
2. Wikesjo, U.M., Polimeni, G., & Qahash, M. Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives. Clin Implant Dent Relat Res 7, 112, 2005.
3. Tayalia, P., & Mooney, D.J. Controlled growth factor delivery for tissue engineering. Adv Mater 21, 3269, 2009.
4. Chen, C., Loe, F., Blocki, A., Peng, Y., & Raghunath, M. Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies. Adv Drug Deliv Rev 63, 277, 2011.
5. Lee, K., Silva, E.A., & Mooney, D.J. Growth factor deliverybased tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8, 153, 2011.
6. Rosen, V., & Thies, R.S. The BMP proteins in bone formation and repair. Trends Genet 8, 97, 1992.
7. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755, 1994. Erratum in: J Cell Biol 128, following 713, 1995.
8. Chen, D., Zhao, M., & Mundy, G.R. Bone morphogenetic proteins. Growth Factors 22, 233, 2004.
9. Tsuji, K., Bandyopadhyay, A., Harfe, B.D., Cox, K., Kakar, S., Gerstenfeld, L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38, 1424, 2006.
10. Rosen, V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20, 475, 2009.
11. Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L., & Riedel, G.E. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395, 110, 2002.
12. Vaccaro, A.R., Patel, T., Fischgrund, J., Anderson, D.G., Truumees, E., Herkowitz, H., et al.Apilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 12, 495, 2003.
13. Mroz, T.E., Wang, J.C., Hashimoto, R., & Norvell, D.C. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976) 35, S86, 2010.
14. Spengler, D.M. Resetting standards for sponsored research: do conflicts influence results? Spine J 11, 492, 2011.
15. Freire, M.O.,You,H.K., Kook, J.K.,Choi, J.H., & Zadeh,H.H. Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies. Tissue Eng Part A 17, 2911, 2011.
16. Bosch, C., Melsen, B., & Vargervik, K. Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg 9, 310, 1998.
17. Cowan, C.M., Shi, Y.Y., Aalami, O.O., Chou, Y.F., Mari, C., Thomas, R., et al. Adipose-derived adult stromal cells heal critical-sizemouse calvarial defects.Nat Biotechnol 22, 560, 2004.
18. Artym, V.V., & Matsumoto, K. Imaging cells in threedimensional collagen matrix. Curr Protoc Cell Biol Chapter 10:Unit 10.18.1-20, 2010.
19. Bandyopadhyay, A., Tsuji, K., Cox, K., Harfe, B.D., Rosen, V., & Tabin, C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2, e216, 2006.
20. Zhu, W., Rawlins, B.A., Boachie-Adjei, O., Myers, E.R., Arimizu, J., Choi, E., et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res 19, 2021, 2004.
21. Carragee, E.J., Hurwitz, E.L., & Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11, 471, 2011.
22. Woo, E.J. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 70, 765, 2012.
23. Perri, B., Cooper, M., Lauryssen, C., & Anand, N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 7, 235, 2007.
24. Hwang, C.J., Vaccaro, A.R., Lawrence, J.P., Hong, J., Schellekens, H., Alaoui-Ismaili, M.H., et al. Immunogenicity of bone morphogenetic proteins. J Neurosurg Spine 10, 443, 2009.